Pre-solicitationPosted Jul 29, 2026·Responses due Aug 7, 2026

Upgrade to the Zeiss Serial Block Face Scanning Electron Microscope

National Institutes of Health · NATIONAL INSTITUTES OF HEALTH OLAO

Stage
Early notice (sources sought, presolicitation or special notice)
NAICS
334516
Value
Not stated
Solicitation
75N98026Q00902
Set-aside
None stated
PSC
6640
Place
Bethesda, MD, USA
Contact
Trish Haun (haunp@mail.nih.gov)
Loading your pipeline and notes…
CSV Email

Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.

Where this opportunity stands

Every notice posted under solicitation 75N98026Q00902 in this department, oldest first.

Early notice
  • Jul 29, 2026 · this notice
    Pre-solicitation
Solicitation
None posted
Award
Not yet. Typical award: Sep 7, 2026 to May 30, 2027, middle of the range Oct 1, 2026.
Measured from 68 past early notices at National Institutes of Health that later posted an award (middle half of cases, counted from Jul 29, 2026).

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

  • Answer the notice: this is when the requirement can still be shaped.
  • Contact the contracting officer named on the notice.
  • Check who won similar work; they are the likely bidders.

What the notice says

Authority: FAR 6.302-1 � Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements Contracting Activity: National Institute of Biomedical Imaging and Bioengineering (NIBIB) Proposed Contractor: Carl Zeiss Description of Requirement This is an upgrade to the Zeiss Serial Block Face Scanning Electron Microscope. This instrument is used to study the three-dimensional structure of cells and tissues using the serial block face (SBF) imaging technique using an ultramicrotome built into the specimen chamber of the SEM. Justification for Sole Source NIBIB intends t… (show all)

o negotiate and award a sole source contract to Carl Zeiss pursuant to FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements. The proposed upgrade is for an existing Zeiss Serial Block Face Scanning Electron Microscope (SBF-SEM) manufactured by Carl Zeiss AG. This upgrade must be carried out by the original equipment manufacturer because: 1. Proprietary Technology o The upgrade involves proprietary hardware, software, firmware, and system integration developed exclusively by Carl Zeiss. o The technical specifications, source code, calibration procedures, and engineering documentation necessary to perform the upgrade are not available to third-party vendors. 2. System Compatibility o The microscope is an integrated instrument whose imaging performance depends on precise compatibility between the microscope hardware, detectors, stage controls, software, and Serial Block Face system. o Only Carl Zeiss can ensure that the upgraded components are fully compatible with the existing instrument configuration. 3. Factory Calibration and Validation o Following installation, the upgraded system requires factory-approved calibration, alignment, and performance verification to meet manufacturer specifications. o These procedures require proprietary service tools, software, and trained factory-certified engineers. 4. Preservation of Warranty and Service Support o Installation by any non-authorized organization could invalidate manufacturer warranties, future service agreements, software support, or eligibility for future upgrades. o Carl Zeiss maintains responsibility for continued maintenance, software updates, and technical support of the upgraded system. 5. No Equivalent Alternative o No other vendor has the legal authority, proprietary knowledge, or access to OEM components necessary to provide an equivalent upgrade while maintaining the instrument's specified performance. o Third-party service providers cannot supply genuine Zeiss upgrade kits or certify the system to manufacturer performance specifications. 6. Research Continuity o The upgraded system must maintain continuity with existing research protocols, imaging workflows, and previously acquired datasets. o Using the OEM upgrade minimizes downtime and reduces technical risks that could negatively affect ongoing research. Notice to Interested Parties This notice is not a request for competitive quotations or proposals. However, any responsible source, including small businesses, 8(a) firms, HUBZone small businesses, service-disabled veteran-owned small businesses (SDVOSBs), women-owned small businesses (WOSBs), veteran-owned small businesses (VOSBs), and small disadvantaged businesses (SDBs), may submit a capability statement demonstrating its ability to satisfy the Government's requirement. Capability statements will be evaluated solely to determine whether a competitive procurement should be conducted. A determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the Government's discretion. Anticipated Award The Government anticipates making an award approximately five (5) calendar days after the closing date of this notice unless the Government determines that another responsible source is capable of satisfying the Government's requirements. Capability statements must be submitted via email to haunp@mail.nih.gov no later than 9:00 a.m. EDT on August 7, 2026.

Who won similar work

10 award notices on SAM.gov in the last 24 months. Matched by: Same office (NATIONAL INSTITUTES OF HEALTH OLAO), same product/service code (PSC) 6640 and NAICS 334516.

Single-winner award sizes (10): middle half $37K to $188K, median $61K; range $21K to $230K.

WinnerAwardsValueLast
BRUKER NANO, INC · $BRKR · $3.0B1$230KAug 14, 2026
Sony Biotechnology Inc.1$227KAug 17, 2026
NEWPORT CORP1$212KJul 8, 2026
AMUZA INC.1$115KJul 10, 2026
PARSE BIOSCIENCES, INC.1$67KJul 8, 2026
Mirion Technologies (Capintec), Inc.1$56KJun 29, 2026
NIKON INSTRUMENTS INC1$40KSep 25, 2026
SR RESEARCH LIMITED1$37KJul 8, 2026
BECKMAN COULTER, INC1$31KJul 10, 2026
Revvity Health Sciences, Inc.1$21KOct 9, 2026

Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.

Investor context
  • $BRKR reported $3.0B revenue in FY2025. The median single-winner award in these 10 past awards, $61K, is under 0.1% of that. 10-K

One award's total value against one year of revenue; many awards are paid over several years.

Latest awards

Competitive landscape

For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

  • 0 of these past winners lobbied Natl Institutes of Health (NIH) since 2024 (0 filings)
  • 0 of their lobbyists list a past Natl Institutes of Health (NIH) job
  • No corporate PAC money from them to the overseeing committees since 2024
  • 0 foreign-agent (FARA) registrations
See who and the source records with Pro

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

  • 0 bills named on the past winners' lobbying filings
  • 0 rules from the department in the last 12 months
  • 0 executive orders naming the agency in the last 12 months
See who and the source records with Pro

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.

  • 1 of the past winners are listed companies
  • 0 insider buys and 0 insider sells at them in the last 90 days
See who and the source records with Pro

Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.

Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.